WB4101-Related Compounds: New, Subtype-Selective α1-Adrenoreceptor Antagonists (or Inverse Agonists?)
- 3 November 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 49 (24) , 7140-7149
Abstract
Our previous structure−affinity relationship study had considered the enantiomers of the naphthodioxane, tetrahydronaphthodioxane, and 2-methoxy-1-naphthoxy analogues (compounds 1, 3, and 2, respectively) of 2-(2,6-dimethoxyphenoxyethylaminomethyl)-1,4-benzodioxane, the well-known α1-adrenoceptor (α1-AR) antagonist WB4101, showing that such modifications significantly modulate the affinity and selectivity profile for α1-AR subtypes and 5-HT1A receptor. Here, we extend investigations to antagonist activity enclosing new enantiomeric pairs, namely those of the methoxytetrahydronaphthoxy and methoxybiphenyloxy WB4101 analogues (4 and 5 − 7, respectively) and of a double-modified WB4101 derivative (8) resulting from hybridization between 2 and 3. We found that (S)-2 is a very potent (pA2 10.68) and moderately selective α1D-AR antagonist and the hybrid (S)-8 is a potent (pA2 7.98) and highly selective α1A-AR antagonist. Both of these compounds and (S)-WB4101 seem to act as inverse agonists in a vascular model. The results, which generally validate the logic we followed in designing these eight compounds, are acceptably rationalized by comparative SAR analysis of binding and functional affinities.Keywords
This publication has 14 references indexed in Scilit:
- QSAR study for a novel series of ortho disubstituted phenoxy analogues of α1-adrenoceptor antagonist WB4101European Journal of Medicinal Chemistry, 2006
- QSAR study for a novel series of ortho monosubstituted phenoxy analogues of α1-adrenoceptor antagonist WB4101Bioorganic & Medicinal Chemistry, 2005
- Structure–affinity studies for a novel series of homochiral naphtho and tetrahydronaphtho analogues of α1 antagonist WB-4101Bioorganic & Medicinal Chemistry, 2004
- Binding site analysis of full-length α1a adrenergic receptor using homology modeling and molecular dockingBiochemical and Biophysical Research Communications, 2004
- Synthesis of Homochiral 5- and 8- Substituted 2-[((2-(2,6-Dimethoxyphenoxy)- ethyl)amino)methyl]-1,4-benzodioxanes and Electrophoretic Determination of Their Enantiomeric ExcessThe Journal of Organic Chemistry, 2001
- A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster α 1B -adrenoceptorsNaunyn-Schmiedeberg's Archives of Pharmacology, 2001
- Phe-308 and Phe-312 in Transmembrane Domain 7 Are Major Sites of α1-Adrenergic Receptor Antagonist BindingJournal of Biological Chemistry, 2001
- α1-Adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moietyPharmaceutica Acta Helvetiae, 2000
- Functional evidence of inverse agonism in vascular smooth muscleBritish Journal of Pharmacology, 1996
- pA2 and receptor differentiation: A statistical analysis of competitive antagonismLife Sciences, 1979